Trial Profile
A randomized, open-label, crossover, single-center study evaluated the efficacy of insulin glulisine versus insulin aspart in male patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 Mar 2016 New trial record